Firmenprofil zu DA32 Life Science Tech Acquisition Corp. Aktie
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Erhalte tagesaktuelle Insights vom finAgent über DA32 Life Science Tech Acquisition Corp.
Unternehmensdaten
NameDA32 Life Science Tech Acquisition Corp.
FirmaDA32 Life Science Tech Acquisition Corp.
SymbolDALS
Heimatbörse
NASDAQ
ISINUS23312M1062
WertpapierartAktie
SektorFinancial Services
BrancheShell Companies
CEOSteven Kafka
Marktkapitalisierung264 Mio
LandVereinigte Staaten von Amerika
WährungUSD
Mitarbeiter-
Adresse345 Park Avenue South, 10010 New York City
IPO Datum2021-07-28
Ticker Symbole
Name
Symbol
NASDAQ
DALS
Weitere Aktien
Investoren, die DA32 Life Science Tech Acquisition Corp. halten, haben auch folgende Aktien im Depot: